Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:08:32 EDT Fri 15 May 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:INM - INMED PHARMACEUTICALS INC - https://www.inmedpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INM - Q0.10.603·0.78970.10.6401-0.01-1.510.75300.6633  0.6849  0.64017.98  0.57518:23:05May 0615 min RT 2¢

Recent Trades - Last 10 of 30
Time ETExPriceChangeVolume
18:23:05Q0.65-0.000121
18:23:05Q0.6401-0.01379
16:00:01Q0.65150.001462
16:00:01Q0.65150.00141
15:58:21Q0.6401-0.01366
15:58:17Q0.660.0099900
15:39:13Q0.68490.0348107
15:34:03Q0.66330.013290
15:34:03Q0.6760.0259160
15:00:14Q0.6501 2

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-06 19:36U:INMSEDAR Interim MD & ASEDAR Interim MD & A
2026-05-06 19:35U:INMSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-05-06 18:01U:INMNews ReleaseInMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
2026-04-27 17:31U:INMNews ReleaseInMed Pharmaceuticals Amends Preferred Investment Options
2026-03-27 17:06U:INMNews ReleaseInMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
2026-03-23 07:31U:INMNews ReleaseInMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program
2026-03-09 07:32U:INMNews ReleaseInMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
2026-03-06 17:06U:INMNews ReleaseInMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
2026-02-11 21:11U:INMSEDAR Interim Financial StatementsSEDAR Interim MD & A
2026-02-11 17:24U:INMNews ReleaseInMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
2025-12-17 20:01U:INMNews ReleaseInMed Announces Results of 2025 Annual General and Special Meeting
2025-12-12 17:32U:INMNews ReleaseInMed Provides Update on BayMedica Commercial Business
2025-11-18 07:31U:INMNews ReleaseInMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
2025-11-07 12:13U:INMSEDAR Interim MD & ASEDAR Interim MD & A
2025-11-07 12:07U:INMSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-06 16:52U:INMNews ReleaseInMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
2025-10-16 08:31U:INMNews ReleaseInmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
2025-10-09 08:32U:INMNews ReleaseInMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors
2025-09-24 13:33U:INMSEDAR MD & ASEDAR Annual Report
2025-09-24 13:27U:INMSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements